✦ LIBER ✦

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

✍ Scribed by Razak, A R A; Hotte, S J; Siu, L L; Chen, E X; Hirte, H W; Powers, J; Walsh, W; Stayner, L-A; Laughlin, A; Novotny-Diermayr, V

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of sor

✍ Hironobu Minami; Kenji Kawada; Hiromichi Ebi; Koichi Kitagawa; Yon-il Kim; Kazuh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

A phase I study of the safety and pharma

✍ Lassen, U; Molife, L R; Sorensen, M; Engelholm, S-A; Vidal, L; Sinha, R; Penson, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 316 KB

Phase I and pharmacokinetic study of XR1

✍ de Jonge, M J A; Kaye, S; Verweij, J; Brock, C; Reade, S; Scurr, M; van Doorn, L 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 127 KB

A phase I dose escalation study of the p

✍ Edwina N. Scott; Anne L. Thomas; L. Rhoda Molife; Samreen Ahmed; Sarah Blagden; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 253 KB

Phase I dose-finding study and a pharmac

✍ Iñaki F. Trocòniz; María J. Garrido; Cristina Segura; Josep-María Cendrós; Paola 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 293 KB

Phase I and pharmacological study of the

✍ Konings, I R H M; de Jonge, M J A; Burger, H; van der Gaast, A; van Beijsterveld 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB